Risks of Death and Severe Disease in Patients With Middle East Respiratory Syndrome Coronavirus, 2012–2015

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging pathogen, first recognized in 2012, with a high case fatality risk, no vaccine, and no treatment beyond supportive care. We estimated the relative risks of death and severe disease among MERS-CoV patients in the Middle East betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivers, Caitlin M., Majumder, Maimuna S., Lofgren, Eric T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
ORIGINAL CONTRIBUTIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023790/
https://www.ncbi.nlm.nih.gov/pubmed/27608662
http://dx.doi.org/10.1093/aje/kww013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023790/
https://www.ncbi.nlm.nih.gov/pubmed/27608662
http://dx.doi.org/10.1093/aje/kww013

Ejemplares similares